America Great Health (AAGH) Net Equity Issued and Repurchased (2023 - 2025)

America Great Health has reported Net Equity Issued and Repurchased for 3 years, with the latest figure at $25000.0 in Q1 2025.

• On a quarterly basis, Net Equity Issued and Repurchased fell 81.15% year-over-year to $25000.0 in Q1 2025; TTM through Dec 2025 was $25000.0, a 34.49% decrease from a year earlier, with the FY2025 full-year figure at $102116.0, down 11.2% from the prior year.
• Net Equity Issued and Repurchased was $25000.0 for Q1 2025 at America Great Health, up from $9116.0 in the prior quarter.
• The five-year high for Net Equity Issued and Repurchased was $153956.0 in Q4 2023, with the low at -$171582.0 in Q2 2024.
• Average Net Equity Issued and Repurchased over 3 years is $30414.5, with a median of $20100.0 recorded in 2023.
• The largest YoY upside for Net Equity Issued and Repurchased was 772.54% in 2024 against a maximum downside of 1659.84% in 2024.
• Over 3 years, Net Equity Issued and Repurchased stood at $153956.0 in 2023, then tumbled by 94.08% to $9116.0 in 2024, then jumped by 174.24% to $25000.0 in 2025.
• The last three Net Equity Issued and Repurchased figures came in at $25000.0 (Q1 2025), $9116.0 (Q4 2024), and $68000.0 (Q3 2024), per Business Quant data.